Drug
Setogepram clinical trials
Also written PBI-4050.
How studies write it
Studies that test it under each name
Studies by the year they started
7 studies that test it; most in 2017 (3)
| Year | Studies |
|---|---|
| 2015 | 2 |
| 2016 | 1 |
| 2017 | 3 |
| 2022 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 7 · Other 0
Liminal BioSciences Ltd. (7)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses setogepram is read from its arms, and is right about nine times in ten.
Testing it · 7
- A Healthy Volunteer Study to Compare Fezagepras (PBI-4050) With Sodium PhenylbutyrateTerminatedPhase 1Liminal BioSciences Ltd.NCT05349435Written as Fezagepras
- Study of Safety, Tolerability & Efficacy in Cystic Fibrosis Patients With Abnormal Glucose ToleranceTerminatedPhase 2Liminal BioSciences Ltd.NCT02955888Written as PBI4050
- Study to Evaluate Safety, Efficacy of PBI-4050 & Its Effect on Relevant Biomarkers in T2DM Patients With Metabolic SyndromeTerminatedPhase 2Liminal BioSciences Ltd.NCT03081598Written as PBI-4050
- Open-Label Rollover Study of PBI 4050 in Subjects With Alström SyndromeTerminatedPhase 2/3Liminal BioSciences Ltd.NCT03184584Written as PBI-4050
- A Phase 2 Study to Evaluate the Safety and Tolerability of PBI-4050 in Patients With Idiopathic Pulmonary Fibrosis (IPF)CompletedPhase 2Liminal BioSciences Ltd.NCT02538536Written as PBI4050
- Safety and Tolerability of PBI-4050 and Its Effects on the Biomarkers in Subjects With Alström SyndromeCompletedPhase 2Liminal BioSciences Ltd.NCT02739217Written as PBI-4050
- Study to Evaluate the Safety and Tolerability of PBI-4050 in Type 2 Diabetes Patients With Metabolic SyndromeCompletedPhase 2Liminal BioSciences Ltd.NCT02562573Written as PBI4050
Codes
What other systems call setogepram · ClinicalTrials.gg INT001217
- MeSH (NLM) C000655033setogepramOne source NLM
- UNII (FDA) 879OVM0Y1SFEZAGEPRASConfirmed FDA, NLM, Wikidata
- Wikidata Q27895887setogepramConfirmed FDA, NLM, Wikidata
- DrugBank DB15447One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C000655033 | setogepram | One source NLM |
| UNII (FDA) | 879OVM0Y1S | FEZAGEPRAS | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q27895887 | setogepram | Confirmed FDA, NLM, Wikidata |
| DrugBank | DB15447 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.